Stalking influenza

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 31, 2010, Pages 13563-13564

  Eckert, Debra M ^a   Kay, Michael S ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; VIRUS HEMAGGLUTININ; INFLUENZA VIRUS HEMAGGLUTININ;

HUMAN; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MEMBRANE FUSION; NONHUMAN; NOTE; PH; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN STRUCTURE; VIRUS STRAIN; CHEMISTRY; GENETICS; IMMUNOLOGY; METABOLISM; ORTHOMYXOVIRUS INFECTION;

HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; ORTHOMYXOVIRIDAE INFECTIONS;

EID: 77956366103     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1008672107     Document Type: Note

References (17)

1. Skehel JJ, Wiley DC (2000) Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69:531-569.
2. Bommakanti G, et al. (2010) Design of an HA2 based E. coli expressed influenza immunogen that protects mice from lethal challenge. Proc Natl Acad Sci USA 107:13701-13706.
3. Knossow M, Skehel JJ (2006) Variation and infectivity neutralization in influenza. Immunology 119:1-7.
4. Wiley DC, Wilson IA, Skehel JJ (1981) Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289:373-378.
5. Okuno Y, Isegawa Y, Sasao F, Ueda S (1993) A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J Virol 67:2552-2558. (Pubitemid 23118850)
6. Ekiert DC, et al. (2009) Antibody recognition of a highly conserved influenza virus epitope. Science 324:246-251.
7. Throsby M, et al. (2008) Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS ONE 3:e3942.
8. Wang TT, et al. (2010) Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. PLoS Pathog 6:e1000796.
9. Chen J, et al. (1995) A soluble domain of the membrane-anchoring chain of influenza virus hemagglutinin (HA2) folds in Escherichia coli into the low-pH-induced conformation. Proc Natl Acad Sci USA 92:12205-12209. (Pubitemid 26014039)
10. Suzuki Y, Nei M (2002) Origin and evolution of influenza virus hemagglutinin genes. Mol Biol Evol 19:501-509. (Pubitemid 34289425)
11. Steel J, et al. (2010) Influenza virus vaccine based on the conserved hemagglutinin stalk domain. mBio, 10.1128/mBio.00018-10.
12. Du L, Zhou Y, Jiang S (2010) Research and development of universal influenza vaccines. Microbes Infect 12:280-286.
13. Malakhov MP, et al. (2006) Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection. Antimicrob Agents Chemother 50:1470-1479.
14. Sharma D, et al. (2005) Protein minimization of the gp120 binding region of human CD4. Biochemistry 44:16192-16202. (Pubitemid 41785817)
15. Bhattacharyya S, et al. Design of a non-glycosylated outer domain derived HIV-1 gp120 immunogen that binds to CD4 and induces neutralizing antibodies. J Biol Chem, in press.
16. Sauter NK, et al. (1992) Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: Analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography. Biochemistry 31:9609-9621.
17. Bullough PA, Hughson FM, Skehel JJ, Wiley DC (1994) Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371:37-43. (Pubitemid 24277462)